News
France 24 on MSN1h
The big business behind weight-loss drugs: Global market to hit $150 billion by 2035They burst onto the scene four years ago and are taking over the pharmaceutical world. New GLP-1-based drugs like Ozempic, Wegovy or Zepbound are said to be a weight-loss game changer and could drive ...
Wegovy (semaglutide) will no longer be available through Hims & Hers Health, as Novo Nordisk has ended its short-lived partnership.
Weight loss jabs such as Wegovy and Mounjaro could be handed out “on the high street, or at any out-of-two shopping centre”, ...
To date, almost 400 reports of acute pancreatitis have been received from people using GLP-1 drugs such as Mounjaro, Wegovy, ...
As weight-loss injections like Mounjaro and Wegovy soar in popularity across the UK, jewellers say they’re seeing an unexpected side effect: wedding and engagement rings no longer fit, and in they are ...
Weight loss drugs can’t replace the power of group support for lasting weight loss, says local expert A Slimming World ...
5hon MSN
A nurse has revealed a potentially life-threatening mistake GPs could be making when prescribing revolutionary weight loss ...
This follows "hundreds of reports of acute and chronic pancreatitis from people who have taken drugs such as Mounjaro, ...
The British drug agency is monitoring a possible increase in cases of the disease, although there is no data yet to warrant ...
As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised ...
A PIL has claimed that licences for these drugs were issued without adequate data or India-specific trials and studies, ...
New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results